Deborah M. Messemer - Net Worth and Insider Trading
Deborah M. Messemer Net Worth
The estimated net worth of Deborah M. Messemer is at least $971,606 dollars as of 2024-04-28. Deborah M. Messemer is the Director of TPG Inc and owns about 18,033 shares of TPG Inc (TPG) stock worth over $791,108. Deborah M. Messemer is also the Director of Allogene Therapeutics Inc and owns about 62,456 shares of Allogene Therapeutics Inc (ALLO) stock worth over $180,498. Details can be seen in Deborah M. Messemer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Deborah M. Messemer has not made any transactions after 2024-02-28 and currently still holds the listed stock(s).
Transaction Summary of Deborah M. Messemer
Deborah M. Messemer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Deborah M. Messemer owns 3 companies in total, including Allogene Therapeutics Inc (ALLO) , PayPal Holdings Inc (PYPL) , and TPG Inc (TPG) .
Click here to see the complete history of Deborah M. Messemer’s form 4 insider trades.
Insider Ownership Summary of Deborah M. Messemer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALLO | Allogene Therapeutics Inc | 2023-12-18 | director |
| PYPL | PayPal Holdings Inc | 2019-01-16 | director |
| TPG | TPG Inc | 2024-02-28 | director |
Deborah M. Messemer Latest Holdings Summary
Deborah M. Messemer currently owns a total of 2 stocks. Among these stocks, Deborah M. Messemer owns 18,033 shares of TPG Inc (TPG) as of February 28, 2024, with a value of $791,108 and a weighting of 81.42%. Deborah M. Messemer also owns 62,456 shares of Allogene Therapeutics Inc (ALLO) as of December 18, 2023, with a value of $180,498 and a weighting of 18.58%.
Latest Holdings of Deborah M. Messemer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TPG | TPG Inc | 2024-02-28 | 18,033 | 43.87 | 791,108 |
| ALLO | Allogene Therapeutics Inc | 2023-12-18 | 62,456 | 2.89 | 180,498 |
Holding Weightings of Deborah M. Messemer
Deborah M. Messemer Form 4 Trading Tracker
According to the SEC Form 4 filings, Deborah M. Messemer has made a total of 1 transactions in TPG Inc (TPG) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in TPG Inc is the sale of 6,390 shares on February 28, 2024, which brought Deborah M. Messemer around $280,968.
According to the SEC Form 4 filings, Deborah M. Messemer has made a total of 1 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Allogene Therapeutics Inc is the sale of 18,640 shares on December 18, 2023, which brought Deborah M. Messemer around $50,328.
Insider Trading History of Deborah M. Messemer
- 1
Deborah M. Messemer Trading Performance
Deborah M. Messemer Ownership Network
Ownership Network List of Deborah M. Messemer
Ownership Network Relation of Deborah M. Messemer
Deborah M. Messemer Owned Company Details
What does Allogene Therapeutics Inc do?
Who are the key executives at Allogene Therapeutics Inc?
Deborah M. Messemer is the director of Allogene Therapeutics Inc. Other key executives at Allogene Therapeutics Inc include CHIEF FINANCIAL OFFICER Geoffrey M. Parker , GENERAL COUNSEL Earl Martin Douglas , and SVP & Finance Yinlin Jack Chen .
Allogene Therapeutics Inc (ALLO) Insider Trades Summary
Over the past 18 months, Deborah M. Messemer made 1 insider transaction in Allogene Therapeutics Inc (ALLO) with a net sale of 18,640. Other recent insider transactions involving Allogene Therapeutics Inc (ALLO) include a net sale of 11,602 shares made by Veer Bhavnagri , a net sale of 10,000 shares made by Stephen Mayo , and a net purchase of 190 shares made by Geoffrey M. Parker .
In summary, during the past 3 months, insiders sold 0 shares of Allogene Therapeutics Inc (ALLO) in total and bought 190 shares, with a net purchase of 190 shares. During the past 18 months, 40,242 shares of Allogene Therapeutics Inc (ALLO) were sold and 190 shares were bought by its insiders, resulting in a net sale of 40,052 shares.
Allogene Therapeutics Inc (ALLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Allogene Therapeutics Inc Insider Transactions
Deborah M. Messemer Mailing Address
Above is the net worth, insider trading, and ownership report for Deborah M. Messemer. You might contact Deborah M. Messemer via mailing address: C/o Allogene Therapeutics, Inc., 210 East Grand Avenue, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
